130 related articles for article (PubMed ID: 14959858)
1. Farnesyl transferase inhibitors enhance death receptor signals and induce apoptosis in multiple myeloma cells.
Beaupre DM; McCafferty-Grad J; Bahlis NJ; Boise LH; Lichtenheld MG
Leuk Lymphoma; 2003 Dec; 44(12):2123-34. PubMed ID: 14959858
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
3. Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.
Fandy TE; Shankar S; Ross DD; Sausville E; Srivastava RK
Neoplasia; 2005 Jul; 7(7):646-57. PubMed ID: 16026644
[TBL] [Abstract][Full Text] [Related]
4. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
Petak I; Vernes R; Szucs KS; Anozie M; Izeradjene K; Douglas L; Tillman DM; Phillips DC; Houghton JA
Cell Death Differ; 2003 Jun; 10(6):729-39. PubMed ID: 12761581
[TBL] [Abstract][Full Text] [Related]
5. R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways.
Beaupre DM; Cepero E; Obeng EA; Boise LH; Lichtenheld MG
Mol Cancer Ther; 2004 Feb; 3(2):179-86. PubMed ID: 14985458
[TBL] [Abstract][Full Text] [Related]
6. Manumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells.
Frassanito MA; Cusmai A; Piccoli C; Dammacco F
Br J Haematol; 2002 Jul; 118(1):157-65. PubMed ID: 12100143
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.
Shi Y; Gera J; Hsu JH; Van Ness B; Lichtenstein A
Mol Cancer Ther; 2003 Jun; 2(6):563-72. PubMed ID: 12813136
[TBL] [Abstract][Full Text] [Related]
8. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 elimination.
Gómez-Benito M; Marzo I; Anel A; Naval J
Mol Pharmacol; 2005 Jun; 67(6):1991-8. PubMed ID: 15738311
[TBL] [Abstract][Full Text] [Related]
9. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
10. Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis.
Petak I; Douglas L; Tillman DM; Vernes R; Houghton JA
Clin Cancer Res; 2000 Oct; 6(10):4119-27. PubMed ID: 11051265
[TBL] [Abstract][Full Text] [Related]
11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL.
Dai Y; Dent P; Grant S
Mol Pharmacol; 2003 Dec; 64(6):1402-9. PubMed ID: 14645670
[TBL] [Abstract][Full Text] [Related]
13. Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.
Le Gouill S; Pellat-Deceunynck C; Harousseau JL; Rapp MJ; Robillard N; Bataille R; Amiot M
Leukemia; 2002 Sep; 16(9):1664-7. PubMed ID: 12200678
[TBL] [Abstract][Full Text] [Related]
14. Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.
LeBlanc H; Lawrence D; Varfolomeev E; Totpal K; Morlan J; Schow P; Fong S; Schwall R; Sinicropi D; Ashkenazi A
Nat Med; 2002 Mar; 8(3):274-81. PubMed ID: 11875499
[TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
16. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
17. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
Kang J; Bu J; Hao Y; Chen F
Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917
[TBL] [Abstract][Full Text] [Related]
18. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
Robbins MA; Maksumova L; Pocock E; Chantler JK
Endocrinology; 2003 Oct; 144(10):4616-25. PubMed ID: 12960048
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
Lamothe B; Aggarwal BB
J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]